教育講演
多発性硬化症の病態解析・治療モニタリングにおけるMRIの役割
2023 年 40 巻 3 号 p. 218-222
詳細
2023 年 40 巻 3 号 p. 218-222
Magnetic resonance imaging (MRI) is the most important diagnostic tool in multiple sclerosis (MS). Furthermore, MRI is crucial for providing imaging biomarkers for monitoring disease activity and treatment response. Software for measuring the volume of anatomical structures and MS lesions visualized by MRI has been evolving and has frequently been used in research studies and clinical trials. MRI is also useful for evaluating and/or predicting the therapeutic effects of disease–modifying drugs (DMDs) for MS and plays an important role in the early diagnosis of progressive multifocal leukoencephalopathy, a side effect of DMDs. This review summarizes the latest information on MRI as an imaging biomarker in MS.
